- Home
- VNRX vs NVNO Comparison
VNRX vs NVNO Comparison
Compare VNRX & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNRX
- NVNO
- Stock Information
- Founded
- VNRX N/A
- NVNO 1987
- Country
- VNRX United States
- NVNO United States
- Employees
- VNRX N/A
- NVNO N/A
- Industry
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- NVNO Medical/Dental Instruments
- Sector
- VNRX Health Care
- NVNO Health Care
- Exchange
- VNRX Nasdaq
- NVNO Nasdaq
- Market Cap
- VNRX 67.2M
- NVNO 59.4M
- IPO Year
- VNRX N/A
- NVNO N/A
- Fundamental
- Price
- VNRX $0.68
- NVNO $3.28
- Analyst Decision
- VNRX Strong Buy
- NVNO
- Analyst Count
- VNRX 4
- NVNO 0
- Target Price
- VNRX $4.17
- NVNO N/A
- AVG Volume (30 Days)
- VNRX 135.1K
- NVNO 96.4K
- Earning Date
- VNRX 11-14-2024
- NVNO 10-31-2024
- Dividend Yield
- VNRX N/A
- NVNO N/A
- EPS Growth
- VNRX N/A
- NVNO N/A
- EPS
- VNRX N/A
- NVNO N/A
- Revenue
- VNRX $1,285,827.00
- NVNO N/A
- Revenue This Year
- VNRX $180.66
- NVNO N/A
- Revenue Next Year
- VNRX $558.69
- NVNO N/A
- P/E Ratio
- VNRX N/A
- NVNO N/A
- Revenue Growth
- VNRX 88.32
- NVNO N/A
- 52 Week Low
- VNRX $0.43
- NVNO $3.01
- 52 Week High
- VNRX $1.23
- NVNO $6.97
- Technical
- Relative Strength Index (RSI)
- VNRX 50.19
- NVNO 39.99
- Support Level
- VNRX $0.55
- NVNO $3.25
- Resistance Level
- VNRX $0.80
- NVNO $3.68
- Average True Range (ATR)
- VNRX 0.07
- NVNO 0.15
- MACD
- VNRX 0.01
- NVNO 0.03
- Stochastic Oscillator
- VNRX 52.00
- NVNO 9.20
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).